Understanding Helicobacter pylori: Morphology, Pathogenesis, and Identification

Slide Note
Embed
Share

In this detailed lecture, Assistant Professor Dr. Dalya Basil discusses the characteristics, identification methods, growth characteristics, and pathogenesis of Helicobacter pylori. This spiral-shaped, gram-negative rod bacterium is associated with various gastric conditions, including gastritis, ulcers, and even gastric carcinoma. The content covers key aspects such as morphology, culture sensitivity, growth requirements, and mechanisms through which H. pylori causes mucosal damage, involving both bacterial and host factors.


Uploaded on Sep 27, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. Medical Microbiology Asst. Prof. Dr. Dalya Basil

  2. In this lecture. Helicobacter Campylobacter

  3. Helicobacter pylori Helicobacter pylori is a spiral-shaped gram-negative rod. H pylori is associated with antral gastritis, duodenal (peptic) ulcer disease, gastric carcinoma. Other Helicobacter species that infect the gastric mucosa exist but are rare. ulcers, and gastric

  4. Morphology & Identification Typical Organisms H pylori has multiple flagella at one pole and is actively motile. Culture Culture sensitivity can be limited by prior therapy, contamination with other mucosal bacteria, and other factors. H pylori grows in 3 6 days when incubated at 37 C in a microaerophilic environment. The media for primary isolation include Skirrow's medium with vancomycin, polymyxin B, and trimethoprim, chocolate medium, and other selective media with antibiotics (eg, vancomycin, nalidixic acid, amphotericin). The colonies are translucent and 1 2 mm in diameter. Growth Characteristics H pylori is oxidase-positive and catalase-positive, has a characteristic morphology, is motile, and is a strong producer of urease.

  5. Pathogenesis & Pathology H pylori grows optimally at a pH of 6.0 7.0 and would be killed or not grow at the pH within the gastric lumen. Gastric mucus is relatively impermeable to acid and has a strong buffering capacity. On the lumen side of the mucus, the pH is low (1.0 2.0) while on the epithelial side the pH is about 7.4. H pylori is found deep in the mucous layer near the epithelial surface where physiologic pH is present. H pylori also produces a protease that modifies the gastric mucus and further reduces the ability of acid to diffuse through the mucus. H pylori produces potent urease activity, which yields production of ammonia and further buffering of acid. H pylori is quite motile, even in mucus, and is able to find its way to the epithelial surface. H pylori overlies gastric-type but not intestinal- type epithelial cells.

  6. Pathogenesis & Pathology

  7. Pathogenesis & Pathology The mechanisms by which H pylori causes mucosal damage are not well defined but probably involve both bacterial and host factors. The bacteria invade the epithelial cell surface to a limited degree. lipopolysaccharide may damage the mucosal cells, produced by the urease activity may directly damage the cells also. inflammation and Toxins and and the ammonia

  8. Pathogenesis & Pathology Histologically, gastritis is characterized by chronic and active inflammation. Polymorphonuclear and mononuclear cell infiltrates are seen within the epithelium and lamina propria. Vacuoles within cells are often pronounced. Destruction of the epithelium is common, and glandular atrophy may occur. H pylori thus may be a major risk factor for gastric cancer.

  9. Clinical Findings Acute infection can yield an upper gastrointestinal illness with nausea and pain; vomiting and fever may be present also. The acute symptoms may last for less than 1 week or as long as 2 weeks. Once colonized, the H pylori infection persists for years and perhaps decades or even a lifetime. About 90% of patients with duodenal ulcers and 50 80% of those with gastric ulcers have H pylori infection.

  10. Diagnostic Laboratory Tests Specimens Gastric biopsy specimens can be used for histologic examination or minced in saline and used for culture. Blood is collected for determination of serum antibodies. Smears The diagnosis of gastritis and H pylori infection can be made histologically. A gastroscopy procedure with biopsy is required. Routine stains demonstrate gastritis, and Giemsa or special silver stains can show the curved or spiraled organisms. Culture Skirrow's medium with vancomycin, polymyxin B, and trimethoprim, chocolate medium, and other selective media. Antibodies Several assays have been developed to detect serum antibodies specific for H pylori. The serum antibodies persist even if the H pylori infection is eradicated, and the role of antibody tests in diagnosing active infection or following therapy is therefore limited.

  11. Diagnostic Laboratory Tests Special Tests Rapid tests to detect urease activity are widely used for presumptive identification of H pylori in specimens. Gastric biopsy material can be placed onto a urea-containing medium with a color indicator. If H pylori is present, the urease rapidly splits the urea (1 2 days) and the resulting shift in pH yields a color change in the medium. Detection of H pylori antigen in stool specimens is appropriate as a test of cure for patients with known H pylori infection who have been treated. Breathing test13C- or14C-labeled urea is ingested by the patient. If H pylori is present, the urease activity generates labeled CO2that can be detected in the patient's exhaled breath.

  12. Treatment & Control Treatment Triple therapy: metronidazole and either bismuth subsalicylate or bismuth subcitrate plus either amoxicillin or tetracycline for 14 days eradicates H. pylori infection in 70 95% of patients. An acid-suppressing agent given for 4 6 weeks enhances ulcer healing. Proton pump inhibitors directly inhibit H pylori and appear to be potent urease inhibitors. Either 1 week of a proton pump inhibitor plus amoxicillin and clarithromycin or of amoxicillin plus metronidazole also is highly effective. Epidemiology & Control H pylori is present on the gastric mucosa of less than 20% of persons under age 30 but increases in prevalence to 40 60% of persons age 60, including persons who are asymptomatic. In developing countries, the prevalence of infection may be 80% or higher in adults. Person-to-person transmission of H pylori is likely because intrafamilial clustering of infection occurs.

  13. Campylobacter Campylobacters cause both diarrheal and systemic diseases and are among the most widespread causes of infection in the world. The classification of bacteria within the family Campylobacteriaceae has changed frequently. Some species previously classified as campylobacters have been reclassified in the genus Helicobacter. The genus Arcobacter has been created. C jejuni is the prototype organism in the group and is a very common cause of diarrhea in humans.

  14. Campylobacter jejuni & Campylobacter coli C jejuni and Campylobacter coli have emerged as common human pathogens, causing mainly enteritis and occasionally systemic infection. C jejuni and C coli cause infections that are clinically indistinguishable, and laboratories generally do not differentiate between the two species. Between 5% and 10% of infections reported to be caused by C jejuni are probably caused by C coli. These bacteria are at least as common as salmonellae and shigellae as a cause of diarrhea; an estimated 2 million cases occur in the United States each year.

  15. Morphology & Identification Typical Organisms C jejuni and the other campylobacters are gram-negative rods with comma, S, or "gull wing" shapes. They are motile, with a single polar flagellum, and do not form spores.

  16. Culture The culture characteristics are most important in the isolation and identification of C jejuni and the other campylobacters. Selective media are needed, and incubation must be in an atmosphere with reduced O2(5% O2) with added CO2(10% CO2). A relatively simple way to produce the incubation atmosphere is to place the plates in an anaerobe incubation jar and to produce the gas with a commercially available gas-generating pack or by gas exchange. Incubation of primary plates for isolation of C jejuni should be at 42 C. Although C jejuni grows well at 36 37 C, incubation at 42 C prevents growth of most of the other bacteria present in feces, thus simplifying the identification of C jejuni.

  17. Culture Several selective media are in widespread use. Skirrow's medium contains vancomycin, polymyxin B, and trimethoprim to inhibit growth of other bacteria. Other cephalothin or cefoperazone, and inhibitory compounds; because they contain a cephalosporin, they will not grow Campylobacter fetus and several other Campylobacter species. The selective media are suitable for isolation of C jejuni at 42 C; when media without antibiotics are incubated at 36 37 C, other campylobacters may be isolated. The colonies tend to be colorless or gray. They may be watery and spreading or round and convex, and both colony types may appear on one agar plate. selective media also contain antimicrobials, including

  18. Pathogenesis & Pathology The infection is acquired by the oral route from food, drink, or contact with infected products. C jejuni is susceptible to gastric acid, and ingestion of about 104organisms is usually necessary to produce infection. animals or animal The organisms multiply in the small intestine, invade the epithelium, and produce inflammation that results in the appearance of red and white blood cells in the stools. Occasionally, the bloodstream is invaded and a clinical picture of enteric fever invasion coupled with the toxic activity appears to be responsible for the enteritis. develops. Localized tissue

  19. Clinical Findings Clinical manifestations are acute onset of crampy abdominal pain, profuse diarrhea that may be grossly bloody, headache, malaise, and fever. Usually the illness is self-limited to a period of 5 8 days, but occasionally it continues longer. C jejuni isolates are usually susceptible to erythromycin, and therapy shortens the duration of fecal shedding of bacteria. Most cases resolve without antimicrobial therapy.

  20. Diagnostic Laboratory Tests Specimens Diarrheal stool is the usual specimen. Campylobacters from other types of specimens are usually incidental findings or are found in the setting of known outbreaks of disease. Smears Gram-stained smears of stool may show the typical "gull wing"-shaped rods. Dark-field or phase contrast microscopy may show the typical darting motility of the organisms. Culture Culture on the selective media is the definitive test to diagnose C jejuni enteritis. If another species of Campylobacter is suspected, medium without a cephalosporin should be used and incubated at 36 37 C.

  21. Epidemiology & Control Campylobacter enteritis resembles other acute bacterial diarrheas, particularly shigella dysentery. The source of infection may be food (eg, milk, undercooked fowl) or contact with infected animals or humans and their excreta. Outbreaks arising from a common source, eg, unpasteurized milk, may require public health control measures.

  22. Campylobacter fetus C fetus subspecies fetus is an opportunistic pathogen that causes systemic infections patients. It may occasionally cause diarrhea. in immunocompromised The gastrointestinal tract may be the portal of entry when C fetus causes bacteremia and systemic infection. C fetus has several surface array proteins (S protein, MW 100,000 149,000) which form a capsule-like structure on the surface of the organism polysaccharide capsules of pathogens such as Neisseria meningitidis and Streptococcus pneumoniae). (as compared with the

  23. Thank You

Related


More Related Content